Skip to main content
VRAX logo

VRAX · Virax Biolabs Group Ltd

$3.64 -0.24 (-6.19%) At close · Jul 22
Market Cap
$2.90M
Shares
796,988

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 3
Total Value: $5,057,508
Total Shares: 919,547

Institutional Ownership Trend

10 quarters

Holder Concentration

Across 3 13F filers · Δ vs Dec 31, 2025
Top Holder
95.6%
Dec 2023 → Mar 2026 · range 35.5% – 95.6%
+34.2 pts
Top 5
100.0%
Dec 2023 → Mar 2026 · range 99.8% – 100.0%
0.0 pts
Top 10
100.0%
Dec 2023 → Mar 2026 · range 100.0% – 100.0%
0.0 pts
HHI
9,153
Dec 2023 → Mar 2026 · range 2,648 – 9,153
Highly concentrated+4,639

Quarterly Activity

vs Dec 31, 2025
New
2
Increased
0
Decreased
0
Sold Out
4
Unchanged
1
Holder count: -2
Institutional value: +1572.5%
Shares held: +2530.4%

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 3 of 3
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1885827 CUSIP G9495L133 Visit website Investor relations